DZ Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $163M | Sell |
364,513
-439,260
| -55% | -$205M | 0.14% | 116 |
|
|
2025
Q4 | $364M | Sell |
803,773
-537,697
| -40% | -$232M | 0.31% | 76 |
|
|
2025
Q3 | $525M | Buy |
1,341,470
+135,674
| +11% | +$56.7M | 0.46% | 58 |
|
|
2025
Q2 | $537M | Buy |
1,205,796
+244,942
| +25% | +$113M | 0.54% | 52 |
|
|
2025
Q1 | $466M | Sell |
960,854
-9,808
| -1% | -$4.57M | 0.52% | 51 |
|
|
2024
Q4 | $391M | Sell |
970,662
-66,586
| -6% | -$30.9M | 0.4% | 61 |
|
|
2024
Q3 | $482M | Sell |
1,037,248
-54,051
| -5% | -$26M | 0.47% | 54 |
|
|
2024
Q2 | $512M | Buy |
1,091,299
+791,828
| +264% | +$344M | 0.52% | 52 |
|
|
2024
Q1 | $125M | Buy |
299,471
+8,756
| +3% | +$3.7M | 0.13% | 116 |
|
|
2023
Q4 | $118M | Buy |
290,715
+75,345
| +35% | +$27.8M | 0.15% | 112 |
|
|
2023
Q3 | $74.9M | Buy |
215,370
+38,677
| +22% | +$13.5M | 0.11% | 119 |
|
|
2023
Q2 | $62.2M | Buy |
176,693
+22,039
| +14% | +$7.43M | 0.09% | 128 |
|
|
2023
Q1 | $48.7M | Sell |
154,654
-17,346
| -10% | -$5.2M | 0.08% | 147 |
|
|
2022
Q4 | $49.7M | Sell |
172,000
-5,674
| -3% | -$1.73M | 0.09% | 147 |
|
|
2022
Q3 | $51.4M | Sell |
177,674
-29,522
| -14% | -$8.49M | 0.1% | 130 |
|
|
2022
Q2 | $58.4M | Sell |
207,196
-16,096
| -7% | -$4.31M | 0.11% | 128 |
|
|
2022
Q1 | $58.3M | Buy |
223,292
+19,506
| +10% | +$4.63M | 0.09% | 144 |
|
|
2021
Q4 | $45M | Sell |
203,786
-28,486
| -12% | -$5.54M | 0.06% | 177 |
|
|
2021
Q3 | $42.1M | Sell |
232,272
-57,087
| -20% | -$11.1M | 0.07% | 174 |
|
|
2021
Q2 | $58.3M | Sell |
289,359
-52,074
| -15% | -$10.9M | 0.09% | 144 |
|
|
2021
Q1 | $73.4M | Sell |
341,433
-391,304
| -53% | -$85.9M | 0.14% | 113 |
|
|
2020
Q4 | $171M | Sell |
732,737
-1,337,697
| -65% | -$307M | 0.36% | 69 |
|
|
2020
Q3 | $563M | Buy |
2,070,434
+259,727
| +14% | +$71.7M | 1.35% | 16 |
|
|
2020
Q2 | $526M | Buy |
1,810,707
+152,347
| +9% | +$41.3M | 1.45% | 14 |
|
|
2020
Q1 | $395M | Buy |
1,658,360
+22,008
| +1% | +$5.05M | 1.34% | 16 |
|
|
2019
Q4 | $358M | Buy |
1,636,352
+131,528
| +9% | +$26.6M | 0.94% | 27 |
|
|
2019
Q3 | $255M | Buy |
1,504,824
+102,011
| +7% | +$18M | 0.76% | 36 |
|
|
2019
Q2 | $257M | Buy |
1,402,813
+1,385,145
| +7,840% | +$242M | 0.79% | 32 |
|
|
2019
Q1 | $3.25M | Buy |
17,668
+327
| +2% | +$60.4K | 0.01% | 417 |
|
|
2018
Q4 | $2.8M | Buy |
17,341
+1,757
| +11% | +$304K | 0.01% | 421 |
|
|
2018
Q3 | $3M | Buy |
15,584
+15,000
| +2,568% | +$2.67M | 0.01% | 411 |
|
|
2018
Q2 | $99K | Sell |
584
-7,000
| -92% | -$1.09M | ﹤0.01% | 801 |
|
|
2018
Q1 | $1.24M | Buy |
7,584
+7,000
| +1,199% | +$1.14M | ﹤0.01% | 618 |
|
|
2017
Q4 | $87K | Buy |
+584
| New | +$86.5K | ﹤0.01% | 783 |
|
Other funds holding VRTX
VCM
VPM
DZ Bank's VRTX Position: Q1 2026 in Review
DZ Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 55% in Q1 2026, selling an estimated $205M and leaving 364,513 shares worth $163M. The position accounts for 0.14% of the portfolio, ranked #116.
DZ Bank first reported a position in VRTX in Q4 2017 and has held it in 34 quarters since. The position peaked at $563M in Q3 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- DZ Bank held 364,513 shares of Vertex Pharmaceuticals worth $163M as of Q1 2026.
- DZ Bank sold 439,260 Vertex Pharmaceuticals shares in Q1 2026, an estimated $205M.
- Vertex Pharmaceuticals made up 0.14% of DZ Bank's portfolio in Q1 2026, its #116 holding.
- DZ Bank first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
- DZ Bank's Vertex Pharmaceuticals position peaked at $563M in Q3 2020.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.